The Journal of Immunology, Vol 152, Issue 1 343-350, Copyright © 1994 by American Association of Immunologists

ARTICLES

Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis

DA Neumann, NR Rose, AA Ansari and A Herskowitz
Johns Hopkins University, School of Hygiene and Public Health, Department of Immunology and Infectious Diseases, Baltimore, MD 21205.

When mice of certain strains are infected with the cardiotropic virus coxsackievirus B3 or are immunized with mouse cardiac myosin, myocarditis, accompanied by immune recognition of the myocardium, ensues. That both target organ injury and peripheral immunization lead to similar disease manifestations raise questions about the role of tissue damage in eliciting autoantibodies. A/J mice were infected with coxsackievirus B3 or immunized with mouse cardiac myosin and killed at weekly intervals for 4 wk. A portion of each heart was examined histologically for evidence of myocarditis and antibodies were eluted from the remaining heart tissue. Heart eluates and serum were tested for IgG antibodies to myosin and to adenine nucleotide translocator and branched chain ketoacid dehydrogenase molecules by ELISA. At each sampling time, coxsackievirus B3-infected mice exhibited high titers of circulating antibodies to myosin, adenine nucleotide translocator, and branched chain ketoacid dehydrogenase with successively increasing myocardial deposition of antibodies of each specificity. Among myosin- immunized mice, antibodies of all three specificities were eluted from the myocardium and were found in the serum, but only antibodies to myosin were present in appreciable amounts in the circulation. Antibodies to myosin, adenine nucleotide translocator, and branched chain ketoacid dehydrogenase were rarely observed in serum and heart eluates from control animals. This study indicates that myocardial injury may be a prerequisite for the induction of cardiac autoimmunity and suggests that as tissue damage accrues, recognition of additional cardiac Ag may occur.

This article has been cited by other articles:

				D. Fairweather, S. Frisancho-Kiss, D. B. Njoku, J. F. Nyland, Z. Kaya, S. A. Yusung, S. E. Davis, J. A. Frisancho, M. A. Barrett, and N. R. Rose Complement Receptor 1 and 2 Deficiency Increases Coxsackievirus B3-Induced Myocarditis, Dilated Cardiomyopathy, and Heart Failure by Increasing Macrophages, IL-1beta, and Immune Complex Deposition in the Heart J. Immunol., March 15, 2006; 176(6): 3516 - 3524. [Abstract] [Full Text] [PDF]

				D Fairweather and N R Rose Inflammatory heart disease: a role for cytokines Lupus, September 1, 2005; 14(9): 646 - 651. [Abstract] [PDF]

				A. D. Stuart, T. A. McKee, P. A. Williams, C. Harley, S. Shen, D. I. Stuart, T. D. K. Brown, and S. M. Lea Determination of the Structure of a Decay Accelerating Factor-Binding Clinical Isolate of Echovirus 11 Allows Mapping of Mutants with Altered Receptor Requirements for Infection J. Virol., June 27, 2002; 76(15): 7694 - 7704. [Abstract] [Full Text] [PDF]

				M. W. Cunningham Cardiac Myosin and the TH1/TH2 Paradigm in Autoimmune Myocarditis Am. J. Pathol., July 1, 2001; 159(1): 5 - 12. [Full Text] [PDF]

				I. R Mackay Science, medicine, and the future: Tolerance and autoimmunity BMJ, July 8, 2000; 321(7253): 93 - 96. [Full Text]

				S. A. Huber T cells expressing the {gamma}{delta} T cell receptor induce apoptosis in cardiac myocytes Cardiovasc Res, February 1, 2000; 45(3): 579 - 587. [Abstract] [Full Text] [PDF]

				M. W. Cunningham, H. C. Meissner, J. S. Heuser, B. A. Pietra, D. K. Kurahara, and D. Y. M. Leung2 Anti-Human Cardiac Myosin Autoantibodies in Kawasaki Syndrome J. Immunol., July 15, 1999; 163(2): 1060 - 1065. [Abstract] [Full Text] [PDF]

				E. E. Adderson, A. R. Shikhman, K. E. Ward, and M. W. Cunningham Molecular Analysis of Polyreactive Monoclonal Antibodies from Rheumatic Carditis: Human Anti-N-Acetylglucosamine/Anti-Myosin Antibody V Region Genes J. Immunol., August 15, 1998; 161(4): 2020 - 2031. [Abstract] [Full Text] [PDF]

				M. P. Reyes, R. Khatib, G. Khatib, K.L. Ho, F. Smith, and R. A. Kloner Prolonged Captopril Therapy in Murine Viral Myocarditis Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(1): 43 - 49. [Abstract] [PDF]

				J. W. Mason, J. B. O'Connell, A. Herskowitz, N. R. Rose, B. M. McManus, M. E. Billingham, T. E. Moon, and The Myocarditis Treatment Trial Investigators A Clinical Trial of Immunosuppressive Therapy for Myocarditis N. Engl. J. Med., August 3, 1995; 333(5): 269 - 275. [Abstract] [Full Text] [PDF]